Q Global Advisors, LLC Ascendis Pharma A/S Transaction History

Q Global Advisors, LLC

$123 Million
Q1 2025

A detailed history of Q Global Advisors, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Q Global Advisors, LLC holds 248,887 shares of ASND stock, worth $39.6 Million. This represents 31.55% of its overall portfolio holdings.

Number of Shares

248,887

Previous 219,459 13.41%

Holding current value

$39.6 Million

Previous $30.2 Million 28.4%

% of portfolio

31.55%

Previous 31.94%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$119.49 - $168.84 $3.52 Million - $4.97 Million	29,428 Added 13.41%	248,887 $38.8 Million
Q2 2024 Aug 14, 2024	SELL	$121.07 - $153.67 $7.94 Million - $10.1 Million	-65,541 Reduced 23.0%	219,459 $29.9 Million
Q3 2023 Nov 14, 2023	BUY	$86.5 - $103.97 $7.79 Million - $9.36 Million	90,000 Added 46.15%	285,000 $26.7 Million
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $6.75 Million - $9.43 Million	96,429 Added 97.83%	195,000 $17.4 Million
Q1 2023 May 15, 2023	SELL	$104.9 - $126.78 $5.54 Million - $6.7 Million	-52,838 Reduced 34.9%	98,571 $10.6 Million
Q4 2022 Feb 14, 2023	BUY	$99.42 - $131.97 $616,404 - $818,214	6,200 Added 4.27%	151,409 $18.5 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $2.12 Million - $2.78 Million	25,209 Added 21.01%	145,209 $16.7 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $3.16 Million - $4.76 Million	-40,500 Reduced 25.23%	120,000 $11.2 Million
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $4.56 Million - $6.06 Million	44,615 Added 38.5%	160,500 $18.8 Million
Q4 2021 Feb 15, 2022	BUY	$127.1 - $169.66 $6.25 Million - $8.34 Million	49,171 Added 73.7%	115,885 $15.6 Million
Q3 2021 Nov 16, 2021	BUY	$112.67 - $176.92 $1.91 Million - $3.01 Million	16,993 Added 34.18%	66,714 $10.6 Million
Q2 2021 Aug 17, 2021	BUY	$121.62 - $145.29 $2.76 Million - $3.29 Million	22,657 Added 83.72%	49,721 $6.54 Million
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $484,814 - $672,693	3,881 Added 16.74%	27,064 $3.49 Million
Q4 2020 Feb 17, 2021	BUY	$151.2 - $182.76 $3.51 Million - $4.24 Million	23,183 New	23,183 $3.87 Million

Others Institutions Holding ASND

# of Institutions

270

Shares Held

61.9M

Call Options Held

151K

Put Options Held

226K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.89B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Q Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Q Global Advisors, LLC with notifications on news.

Account

Q Global Advisors, LLC Ascendis Pharma A/S Transaction History